| Pharmaceutical active ingredients: |
| Meperidine HydrochloridePromethazine Hydrochloride |
| Available forms, composition and doses of Mepergan Fortis: |
| N / A |
| Mepergan Fortis medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AB52 - Pethidine, combinations excluding psycholepticsR06AD52 - Promethazine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mepantin | Meprobamate | Unidentified Pharmaceutical Company |
| Meparfynol | Methylpentynol | Unidentified Pharmaceutical Company |
| Mepatar | Oxytetracycline | Unidentified Pharmaceutical Company |
| Mepavlon | Meprobamate | Unidentified Pharmaceutical Company |
| Mepentamato | Methylpentynol | Unidentified Pharmaceutical Company |
| Meperidol | Meperidine | Unidentified Pharmaceutical Company |
| Meperon | Moperone | Unidentified Pharmaceutical Company |
| Mephadryl | Diphenhydramine | Unidentified Pharmaceutical Company |
| Mephamycin | Erythromycin | Unidentified Pharmaceutical Company |
| Mephanac | 2-Methyl-4-Chlorophenoxyacetic Acid | Unidentified Pharmaceutical Company |